While a direct consensus price target for the AdvisorShares Pure US Cannabis ETF (MSOS) is not currently available on Fintel, it's important to understand why. [cite: 1 (previous search)] Exchange-Traded Funds (ETFs) like MSOS are baskets of securities, and analysts typically issue price targets for the individual companies held within these funds, rather than for the ETF itself. [cite: 3 (previous search)]
To gain insight into the potential valuation of MSOS, investors often look to the analyst price targets of its underlying holdings, particularly the major U.S. Multi-State Operators (MSOs) that constitute a significant portion of the ETF.
For example, Fintel data shows recent one-year average price targets for some prominent US cannabis companies:
- Curaleaf Holdings, Inc. (CURLF/CURA): The average one-year price target is $2.85 (OTCPK) or $3.39 (TSX), with forecasts ranging from $1.36 to $4.42 (OTCPK) or $1.62 to $5.25 (TSX).1
- TerrAscend Corp. (TSNDF/TSND): The average one-year price target is $1.45 (OTCPK) or $1.91 (TSX), with forecasts ranging from $1.15 to $1.79 (OTCPK) or $1.52 to $2.36 (TSX).2
- Trulieve Cannabis Corp. (TCNNF): The average one-year price target is $14.62, with forecasts ranging from $8.99 to $23.78. [cite: 27 (previous search)]
These figures represent the collective sentiment of analysts regarding the fair value of these individual companies over the next 12 months. While not a direct price target for MSOS, analyzing the targets and sentiment of its key components can provide a proxy for the ETF's potential trajectory.
